SCHEMBL13434283

SCHEMBL13434283

CC(C)(C)OC(=O)N1CCC[C@@H](NCc2ccc(Cl)cc2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ ANO1 Q5XXA6 2/20 0.51
▸ USP30 Q70CQ3 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CNR1 P21554 1/20 0.49
▸ CNR2 P34972 1/20 0.49
▸ POLB P06746 1/20 0.48
▸ STS P08842 2/20 0.47
▸ AHCY P23526 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ BCHE P06276 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ BACE1 P56817 1/20 0.45
▸ NR1D1 P20393 2/20 0.44
▸ DPP7 Q9UHL4 1/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14747175 1.00 HTT (0.51) HTTSMN1; SMN2NPSR1ANO1USP30
SCHEMBL651891 0.93 HTT (0.53) HTTSMN1; SMN2NPSR1USP30MEN1
SCHEMBL652820 0.93 HTT (0.53) HTTSMN1; SMN2NPSR1USP30MEN1
SCHEMBL17605154 0.89 USP30 (0.50) SMN1; SMN2USP30MEN1KMT2AALDH1A1
SCHEMBL17605153 0.89 USP30 (0.50) SMN1; SMN2USP30MEN1KMT2AALDH1A1
SCHEMBL17605512 0.89 USP30 (0.50) SMN1; SMN2USP30MEN1KMT2AALDH1A1
SCHEMBL22222650 0.89 USP30 (0.62) USP30STSBCHEACHE
SCHEMBL28779687 0.89 USP30 (0.62) USP30STSBCHEACHE
SCHEMBL1276278 0.87 HTT (0.48) HTTSMN1; SMN2NPSR1USP30MEN1
SCHEMBL652849 0.86 HTT (0.57) HTTSMN1; SMN2NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056497-A1 AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-03-04 — — US disclosed
EP-2119702-A1 AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2009-11-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056497-A1 AMIDE DERIVATIVE REN, AGTR1, AGTR2 HTT 2910/4885SMN1; SMN2 3574/4885NPSR1 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback